Literature DB >> 25810557

Influenza A Virus Panhandle Structure Is Directly Involved in RIG-I Activation and Interferon Induction.

GuanQun Liu1, Hong-Su Park2, Hyun-Mi Pyo3, Qiang Liu4, Yan Zhou5.   

Abstract

UNLABELLED: Retinoic acid-inducible gene I (RIG-I) is an important innate immune sensor that recognizes viral RNA in the cytoplasm. Its nonself recognition largely depends on the unique RNA structures imposed by viral RNA. The panhandle structure residing in the influenza A virus (IAV) genome, whose primary function is to serve as the viral promoter for transcription and replication, has been proposed to be a RIG-I agonist. However, this has never been proved experimentally. Here, we employed multiple approaches to determine if the IAV panhandle structure is directly involved in RIG-I activation and type I interferon (IFN) induction. First, in porcine alveolar macrophages, we demonstrated that the viral genomic coding region is dispensable for RIG-I-dependent IFN induction. Second, using in vitro-synthesized hairpin RNA, we showed that the IAV panhandle structure could directly bind to RIG-I and stimulate IFN production. Furthermore, we investigated the contributions of the wobble base pairs, mismatch, and unpaired nucleotides within the wild-type panhandle structure to RIG-I activation. Elimination of these destabilizing elements within the panhandle structure promoted RIG-I activation and IFN induction. Given the function of the panhandle structure as the viral promoter, we further monitored the promoter activity of these panhandle variants and found that viral replication was moderately affected, whereas viral transcription was impaired dramatically. In all, our results indicate that the IAV panhandle promoter region adopts a nucleotide composition that is optimal for balanced viral RNA synthesis and suboptimal for RIG-I activation. IMPORTANCE: The IAV genomic panhandle structure has been proposed to be an RIG-I agonist due to its partial complementarity; however, this has not been experimentally confirmed. Here, we provide direct evidence that the IAV panhandle structure is competent in, and sufficient for, RIG-I activation and IFN induction. By constructing panhandle variants with increased complementarity, we demonstrated that the wild-type panhandle structure could be modified to enhance RIG-I activation and IFN induction. These panhandle variants posed moderate influence on viral replication but dramatic impairment of viral transcription. These results indicate that the IAV panhandle promoter region adopts a nucleotide composition to achieve optimal balance of viral RNA synthesis and suboptimal RIG-I activation. Our results highlight the multifunctional role of the IAV panhandle promoter region in the virus life cycle and offer novel insights into the development of antiviral agents aiming to boost RIG-I signaling or virus attenuation by manipulating this conserved region.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25810557      PMCID: PMC4442436          DOI: 10.1128/JVI.00232-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  The packaging signal of influenza viral RNA molecules.

Authors:  S Tchatalbachev; R Flick; G Hobom
Journal:  RNA       Date:  2001-07       Impact factor: 4.942

2.  RIG-I forms signaling-competent filaments in an ATP-dependent, ubiquitin-independent manner.

Authors:  Alys Peisley; Bin Wu; Hui Yao; Thomas Walz; Sun Hur
Journal:  Mol Cell       Date:  2013-08-29       Impact factor: 17.970

3.  ATPase-driven oligomerization of RIG-I on RNA allows optimal activation of type-I interferon.

Authors:  Jenish R Patel; Ankur Jain; Yi-ying Chou; Alina Baum; Taekjip Ha; Adolfo García-Sastre
Journal:  EMBO Rep       Date:  2013-07-12       Impact factor: 8.807

4.  5'-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I.

Authors:  Andreas Schmidt; Tobias Schwerd; Wolfgang Hamm; Johannes C Hellmuth; Sheng Cui; Michael Wenzel; Franziska S Hoffmann; Marie-Cecile Michallet; Robert Besch; Karl-Peter Hopfner; Stefan Endres; Simon Rothenfusser
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-02       Impact factor: 11.205

5.  Isolation and characterization of the positive-sense replicative intermediate of a negative-strand RNA virus.

Authors:  Ashley York; Narin Hengrung; Frank T Vreede; Juha T Huiskonen; Ervin Fodor
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-21       Impact factor: 11.205

6.  Defining the functional determinants for RNA surveillance by RIG-I.

Authors:  Andrew Kohlway; Dahai Luo; David C Rawling; Steve C Ding; Anna Marie Pyle
Journal:  EMBO Rep       Date:  2013-07-30       Impact factor: 8.807

7.  Uncoupling of influenza A virus transcription and replication through mutation of the unpaired adenosine in the viral RNA promoter.

Authors:  Aartjan J W te Velthuis; Lauren Turrell; Frank T Vreede; Ervin Fodor
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

8.  Activation of the interferon induction cascade by influenza a viruses requires viral RNA synthesis and nuclear export.

Authors:  Marian J Killip; Matt Smith; David Jackson; Richard E Randall
Journal:  J Virol       Date:  2014-01-29       Impact factor: 5.103

Review 9.  Master sensors of pathogenic RNA - RIG-I like receptors.

Authors:  Martin Schlee
Journal:  Immunobiology       Date:  2013-07-01       Impact factor: 3.144

Review 10.  Cytosolic sensing of viruses.

Authors:  Delphine Goubau; Safia Deddouche; Caetano Reis e Sousa
Journal:  Immunity       Date:  2013-05-23       Impact factor: 31.745

View more
  51 in total

Review 1.  Distinct and Orchestrated Functions of RNA Sensors in Innate Immunity.

Authors:  GuanQun Liu; Michaela U Gack
Journal:  Immunity       Date:  2020-07-14       Impact factor: 31.745

Review 2.  How the Respiratory Epithelium Senses and Reacts to Influenza Virus.

Authors:  Kambez H Benam; Laura Denney; Ling-Pei Ho
Journal:  Am J Respir Cell Mol Biol       Date:  2019-03       Impact factor: 6.914

Review 3.  Cytoplasm and Beyond: Dynamic Innate Immune Sensing of Influenza A Virus by RIG-I.

Authors:  GuanQun Liu; Yan Zhou
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

Review 4.  To Conquer the Host, Influenza Virus Is Packing It In: Interferon-Antagonistic Strategies beyond NS1.

Authors:  Michaela Weber-Gerlach; Friedemann Weber
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

5.  DAI Senses Influenza A Virus Genomic RNA and Activates RIPK3-Dependent Cell Death.

Authors:  Roshan J Thapa; Justin P Ingram; Katherine B Ragan; Shoko Nogusa; David F Boyd; Asiel A Benitez; Haripriya Sridharan; Rachelle Kosoff; Maria Shubina; Vanessa J Landsteiner; Mark Andrake; Peter Vogel; Luis J Sigal; Benjamin R tenOever; Paul G Thomas; Jason W Upton; Siddharth Balachandran
Journal:  Cell Host Microbe       Date:  2016-10-13       Impact factor: 21.023

6.  DAMP-driven metabolic adaptation.

Authors:  Kirsty Minton
Journal:  Nat Rev Immunol       Date:  2020-01       Impact factor: 53.106

7.  ADAR2 Is Involved in Self and Nonself Recognition of Borna Disease Virus Genomic RNA in the Nucleus.

Authors:  Mako Yanai; Shohei Kojima; Madoka Sakai; Ryo Komorizono; Keizo Tomonaga; Akiko Makino
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

8.  Inhibition of Ongoing Influenza A Virus Replication Reveals Different Mechanisms of RIG-I Activation.

Authors:  GuanQun Liu; Yao Lu; Qiang Liu; Yan Zhou
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

9.  Interferon Inducer IFI35 regulates RIG-I-mediated innate antiviral response through mutual antagonism with Influenza protein NS1.

Authors:  Hui Yang; Wendy Winkler; Xiaopeng Wu
Journal:  J Virol       Date:  2021-03-10       Impact factor: 5.103

10.  Defective RNA sensing by RIG-I in severe influenza virus infection.

Authors:  S E Jørgensen; M Christiansen; L B Ryø; H H Gad; J Gjedsted; P Staeheli; J G Mikkelsen; M Storgaard; R Hartmann; T H Mogensen
Journal:  Clin Exp Immunol       Date:  2018-03-24       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.